Imaging of disease activity in graves' orbitopathy with different methods: comparison of 99mtc-dtpa and 99mtc-depreotide single photon emission tomography, magnetic resonance imaging and clinical activity scores

Laszlo Galuska, Andras Leovey, Zsolt Szucs-Farkas, Lajos Szabados, Ildiko Garai, Andras Berta, Erzsebet Balazs, Jozsef Varga, Endre V. Nagy

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The immunosuppressive treatment of Graves' orbitopathy (GO) influences the course of the disease in the early, active, retrobulbar inflammatory phase (active GO), which cannot be detected by direct clinical examination. To evaluate the clinical effectiveness of a newly developed method for the detection of intraorbital inflammatory activity in patients suffering from Graves' orbitopathy, utilizing a four-headed single photon emission tomograph (SPET) camera and 99mTc-diethylenetriamine pentaacetic acid (99mTc-DTPA).

Original languageEnglish
Pages (from-to)407-414
Number of pages8
JournalNuclear medicine communications
Volume26
Issue number5
DOIs
Publication statusPublished - May 2005

Keywords

  • MRI
  • Orbitopathy
  • SPET

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Imaging of disease activity in graves' orbitopathy with different methods: comparison of <sup>99m</sup>tc-dtpa and <sup>99m</sup>tc-depreotide single photon emission tomography, magnetic resonance imaging and clinical activity scores'. Together they form a unique fingerprint.

  • Cite this